دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Melanoma and Racial Health Disparities in Black Individuals—Facts, Fallacies, and Fixes
Michael A. Marchetti, MD1; Adewole S. Adamson, MD, MPP2; Allan C. Halpern, MD1
doi : 10.1001/jamadermatol.2021.2215
JAMA Dermatol. 2021;157(9):1031-1032
Communication Between Dermatologists and Dermatopathologists via the Pathology Requisition
Shane D. B. Smith, MD1; Julie D. R. Reimann, MD, PhD2,3; Thomas D. Horn, MD, MBA2,3
doi : 10.1001/jamadermatol.2021.2582
JAMA Dermatol. 2021;157(9):1033-1034
What Matters the Most to Adult Women With Acne?
Diane Thiboutot, MD1; Andrea Zaenglein, MD1,2; Alison M. Layton, MB, ChB3
doi : 10.1001/jamadermatol.2021.2184
JAMA Dermatol. 2021;157(9):1035-1037
Patient Perspectives on the Lived Experience of Acne and Its Treatment Among Adult Women With Acne:A Qualitative Study
John S. Barbieri, MD, MBA1; Rachel Fulton, BA1,2; Rebecca Neergaard, BS3,4; Maria N. Nelson, MA3,4; Frances K. Barg, PhD, MEd3,4,5; David J. Margolis, MD, PhD1,5
doi : 10.1001/jamadermatol.2021.2185
JAMA Dermatol. 2021;157(9):1040-1046
Acne often persists into adulthood in women. However, few studies have specifically explored the lived experience of acne in adult populations.
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis:A Randomized Clinical Trial
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic DermatitisA Randomized Clinical Trial
doi : 10.1001/jamadermatol.2021.3023
JAMA Dermatol. 2021;157(9):1047-1055
Atopic dermatitis (AD) is a chronic, recurrent, inflammatory skin disease with an unmet need for treatments that provide rapid and high levels of skin clearance and itch improvement.
Association Between Biologics Use and Risk of Serious Infection in Patients With Psoriasis
Laetitia Penso, MSc1,2; Rosemary Dray-Spira, MD, PhD1; Alain Weill, MD1,3; Laura Pina Vegas, MD, MPH2,4; Mahmoud Zureik, MD, PhD1,5; Emilie Sbidian, MD, PhD1,2,6,7
doi : 10.1001/jamadermatol.2021.2599
JAMA Dermatol. 2021;157(9):1056-1065
Biologics and targeted therapies, such as apremilast, are efficient treatments to manage moderate to severe psoriasis. More information about the risk of serious infection is needed for the newest treatment options in a real-world setting.
Evaluation of Long-term Clearance Rates of Interventions for Actinic Keratosis: A Systematic Review and Network Meta-analysis
Theresa Steeb, MPH1,2; Anja Wessely, MSc1,2; Anne Petzold, MSc1,2; Titus J. Brinker, MD3; Lutz Schmitz, MD4,5; Ulrike Leiter, MD6; Claus Garbe, MD6; Oliver Schöffski, MPH7; Carola Berking, MD1,2; Markus V. Heppt, MD, MSc, MHBA1,2
doi : 10.1001/jamadermatol.2021.2779
JAMA Dermatol. 2021;157(9):1066-1077
Multiple interventions are available for the treatment of actinic keratosis (AK). However, most randomized clinical trials and meta-analyses focus on short-term efficacy outcomes.
Assessment of Diagnostic Accuracy of Dermoscopic Structures and Patterns Used in Melanoma Detection: A Systematic Review and Meta-analysis
Natalie M. Williams, MD1; Kristina D. Rojas, BS1; John M. Reynolds, MLIS2; Deukwoo Kwon, PhD3; Jackie Shum-Tien, MD1; Natalia Jaimes, MD1,4
doi : 10.1001/jamadermatol.2021.2845
JAMA Dermatol. 2021;157(9):1078-1088
Dermoscopy increases the diagnostic accuracy for melanoma. However, the accuracy of individual structures and patterns used in melanoma detection has not been systematically evaluated.
Validity of Using Billing Codes From Electronic Health Records to Estimate Skin Cancer Counts
Nimay Anand, BA1; LaVar Edwards, MS2,3; Laura X. Baker, MD, MEd2; Mary-Margaret Chren, MD2; Lee Wheless, MD, PhD2
doi : 10.1001/jamadermatol.2021.2856
JAMA Dermatol. 2021;157(9):1089-1094
Patients can develop multiple skin cancers, and their medical data can be spread over multiple health care systems. This fragmented care, combined with the lack of skin cancer registries, has limited our ability both to provide accurate estimates of incidence and to study the pathogenesis of multiple skin cancers.
Differences Between Children and Adults With Hidradenitis Suppurativa
Katherine K. Hallock, MD1; Marylena R. Mizerak, BS2; Alison Dempsey, MD3; Steven Maczuga, BS, MS1; Joslyn S. Kirby, MD, MS, Med1
doi : 10.1001/jamadermatol.2021.2865
JAMA Dermatol. 2021;157(9):1095-1101
Up to 50% of patients may have hidradenitis suppurativa (HS) onset between age 10 and 21 years. To our knowledge, little is known about how adolescents with HS utilize health care during their journey to receiving a diagnosis.
Association of Second-Opinion Strategies in the Histopathologic Diagnosis of Cutaneous Melanocytic Lesions With Diagnostic Accuracy and Population-Level Costs
Anna N. A. Tosteson, ScD1,2; Stephanie Tapp, PhD1; Linda J. Titus, PhD, MA1,2; Heidi D. Nelson, MD, MPH3; Gary M. Longton, MS4; Mackenzie Bronson1; Margaret Pepe, PhD, MS4; Patricia A. Carney, PhD, MS3; Tracy Onega, PhD, MA, MS1,5; Michael W. Piepkorn, MD6,7; Stevan R. Knezevich, MD, PhD8; Raymond Barnhill, MD9,10; Martin A. Weinstock, MD, PhD11; David E. Elder, MBChB12; Joann G. Elmore, MD, MPH13
doi : 10.1001/jamadermatol.2021.1779
JAMA Dermatol. 2021;157(9):1102-1106
Diagnostic variation among pathologists interpreting cutaneous melanocytic lesions could lead to suboptimal care.
Neonatal Linear IgA Bullous Dermatosis Mediated by Breast Milk–Borne Maternal IgA
Shohei Egami, MD1; Chihiro Suzuki, MD1; Yuichi Kurihara, MD1; Jun Yamagami, MD, PhD1; Akiharu Kubo, MD, PhD1; Takeru Funakoshi, MD, PhD1; Wataru Nishie, MD, PhD2; Kazuya Matsumura, MD3; Takahiro Matsushima, MD4; Miho Kawaida, MD, PhD5; Michiie Sakamoto, MD, PhD5; Masayuki Amagai, MD, PhD1
doi : 10.1001/jamadermatol.2021.2392
JAMA Dermatol. 2021;157(9):1107-1111
Neonatal linear immunoglobulin A (IgA) bullous dermatosis (LABD) is a rare disease that can be fatal when associated with respiratory failure. All previously reported cases of neonatal LABD have been in newborns with healthy asymptomatic mothers, and the pathogenic IgA was of unknown origin.
A Multidisciplinary Collaborative Approach to Retinal Toxic Effects Screening for Dermatology Patients Taking Antimalarials
Nicole Fett, MD, MSCE1; Victoria P. Werth, MS, MD2,3
doi : 10.1001/jamadermatol.2021.2699
JAMA Dermatol. 2021;157(9):1112-1113
What are the roles of antimalarial therapy prescribers and eye care specialists in regard to antimalarial dosing, screening for retinal toxic effects, and antimalarial treatment cessation?
Epidermolytic Hyperkeratosis
Mallory L. Foster, BS1; Jordan M. Jones, MD2; Courtney R. Schadt, MD2
doi : 10.1001/jamadermatol.2021.2325
JAMA Dermatol. 2021;157(9):1114
Tinea Facei From Trichophyton benhamiae From a Pet Guinea Pig
Helena Iznardo, MD1; Cristina Garcia-Melendo, MD1; Carla Berengua, MD2
doi : 10.1001/jamadermatol.2021.2566
JAMA Dermatol. 2021;157(9):1115
Erythematoedematous and Sclerotic Plaques in a Man Receiving Systemic Chemotherapy
Mar Ramírez-Lluch, MD1; Eduardo Bernia, MD1; Onofre Sanmartín-Jiménez, MD, PhD1
doi : 10.1001/jamadermatol.2021.2576
JAMA Dermatol. 2021;157(9):1116-1117
Bright Red Macules of the Lower Legs
Katie A. O’Connell, MS1,2; Michelle S. Min, MD, MS1,3; Avery H. LaChance, MD, MPH1
doi : 10.1001/jamadermatol.2021.2980
JAMA Dermatol. 2021;157(9):1118-1119
Vitiligo
Tessa M. LeWitt, BS1; Roopal V. Kundu, MD1
doi : 10.1001/jamadermatol.2021.1688
JAMA Dermatol. 2021;157(9):1136
Association Between Gender-Affirming Hair Removal and Mental Health Outcomes
Michelle S. Lee, BA1,2; Anthony N. Almazan, BA1,3; Vinod E. Nambudiri, MD, MBA1,2; Alex S. Keuroghlian, MD, MPH1,4,5
doi : 10.1001/jamadermatol.2021.2551
JAMA Dermatol. 2021;157(9):1120-1122
Clinical Settings and Demographic Characteristics of Patients With Sunburn
Malgorzata K. Nowakowska, BS1; Yao Li, MS2; Desmond C. Garner, BA3,4; Carly F. Stender, BS5; Candice L. Hinkston, MPH2; Sharon H. Giordano, MD, MPH2; Mackenzie R. Wehner, MD, MPhil2,6
doi : 10.1001/jamadermatol.2021.2923
JAMA Dermatol. 2021;157(9):1122-1125
Racial and Ethnic Distribution of Patients Hospitalized With Hidradenitis Suppurativa, 2008-2018
Ehizogie Edigin, MD1; Subuhi Kaul, MD1; Precious Obehi Eseaton, MBBS2; Joerg Albrecht, MD, PhD3,4
doi : 10.1001/jamadermatol.2021.2999
JAMA Dermatol. 2021;157(9):1125-1127
Cytotoxic T-Lymphocyte Antigen–4 Haploinsufficiency Cutaneous Manifestations
Fiore Casale, MMS1; Cristina Nguyen, MD, MSBS, MHA1; Suzanne Ward, MD1; Natasha Atanaskova Mesinkovska, MD, PhD1
doi : 10.1001/jamadermatol.2021.2317
JAMA Dermatol. 2021;157(9):1127-1128
Association of Facial Pustular Neutrophilic Eruption With Messenger RNA–1273 SARS-CoV-2 Vaccine
Eric Dean Merrill, MD1; Sakeen W. Kashem, MD, PhD1; Erin H. Amerson, MD1,2; Laura B. Pincus, MD1,3; Ursula E. Lang, MD, PhD1,2,3; Kanade Shinkai, MD, PhD1; Aileen Y. Chang, MD1,2
doi : 10.1001/jamadermatol.2021.2474
JAMA Dermatol. 2021;157(9):1128-1130
